North West Fund backs Dot Medical
The North West Fund for Biomedical, managed by Spark Impact, has invested ТЃ550,000 in Dot Medical, which manufactures equipment to treat heart conditions.
The North West Fund for Biomedical is a sub-fund of the North West Fund, financed by the European Regional Development Fund and the European Investment Bank. The North West Fund is the umbrella term for six funds that back SMEs in the North-West of England.
The investment is the twentieth completed by The North West Fund for Biomedical. It will allow the company to develop and manufacture more equipment.
Company
Headquartered in Macclesfield, Dot Medical develops and manufactures equipment to treat atrial fibrillation, a heart condition that causes irregular and fast heart rates.
Dot Medical reports a turnover of approximately £1.5m and employs 7 members of staff.
People
Penny Attridge is a senior investment director at Spark Impact and worked on the transaction. Ian Rankin is managing director of Dot Medical.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








